Measuring tumour vascular response to antivascular and antiangiogenic drugs.
about
Increase in tumour permeability following TGF-beta type I receptor-inhibitor treatment observed by dynamic contrast-enhanced MRIVascular endothelial growth factor as an anti-angiogenic target for cancer therapyPreclinical molecular imaging of tumor angiogenesis.Three-dimensional analysis of tumour vascular corrosion casts using stereoimaging and micro-computed tomographyIdentification of a characteristic vascular belt zone in human colorectal cancerPhage display peptide probes for imaging early response to bevacizumab treatment.Early quantification of the therapeutic efficacy of the vascular disrupting agent, CKD-516, using dynamic contrast-enhanced ultrasonography in rabbit VX2 liver tumors.Alphastatin downregulates vascular endothelial cells sphingosine kinase activity and suppresses tumor growth in nude mice bearing human gastric cancer xenografts.Multiparametric MRI biomarkers for measuring vascular disrupting effect on cancerRole of the cytoskeleton in formation and maintenance of angiogenic sproutsDynamic contrast-enhanced and diffusion-weighted magnetic resonance imaging noninvasive evaluation of vascular disrupting treatment on rabbit liver tumors.PET imaging of early response to the tyrosine kinase inhibitor ZD4190.Microenvironmental and cellular consequences of altered blood flow in tumours.Dose-response relationship of ultrasound contrast agent in an in vivo murine melanoma modelQuantitative evaluation of viable tissue perfusion changes with contrast-enhanced greyscale ultrasound in a mouse hepatoma model following treatment with different doses of thalidomideDiverse responses to vascular disrupting agent combretastatin a4 phosphate: a comparative study in rats with hepatic and subcutaneous tumor allografts using MRI biomarkers, microangiography, and histopathology.Clinical biomarkers of angiogenesis inhibition.Effects of macrophage metalloelastase on the basic fibroblast growth factor expression and tumor angiogenesis in murine colon cancer.Quantification of Tumor Vascular Permeability and Blood Volume by Positron Emission Tomography.Three-dimensional vasculature reconstruction of tumour microenvironment via local clustering and classification.Esophageal squamous cell carcinoma: assessing tumor angiogenesis using multi-slice CT perfusion imaging.Evaluation of three-dimensional arterial spin labeling perfusion imaging for the pathological investigation of musculoskeletal tumors.[Status and advances of RGD molecular imaging in lung cancer].Quantitative colorectal cancer perfusion measurement by multidetector-row CT: does greater tumour coverage improve measurement reproducibility?
P2860
Q28749643-B2E2835C-D74B-4BC4-B78A-03502CD19865Q30455612-0CE944AF-154F-40C1-B038-E1E5303E4B21Q30475818-0B9546DA-BF83-460C-B0A4-B12278347437Q30640206-1D99B2BF-D7A9-4A39-97D4-3A8DB9CB463CQ33364892-519FA546-8EDF-4B75-B05A-6B1118540C16Q33541076-C7EB871E-E0B1-4159-811E-1C434A2CEE78Q33760493-17DD8D87-FB2E-4380-A994-927DC4094260Q33865977-2DB8DB10-B8D9-4163-80BA-35A019F9F922Q34538659-0DDDD91D-9526-4429-9B04-D29EA76270F7Q34829230-FD373098-30C9-470F-B3B5-C0A86B36C97FQ35077659-EF150F1F-C434-4869-9129-EEBC70917E94Q35249646-73F4003C-0B2F-4D0F-9226-6166D2BEE0F9Q35904989-F6D13C47-E8FA-499A-9E27-9C80A0BF9664Q36295224-1899809D-80DC-45B1-A609-D922FE883A4AQ36324991-B0CC7BB1-3881-476B-B007-20E978BCBFD8Q36613314-B286046A-2F75-4227-9BEF-CF5F8CE43079Q37139413-66DECB06-CE3F-42BC-8527-205F5BC51419Q39495473-93DD72AE-EF98-46A6-B548-1B8D0CF572CCQ41114248-ADFD4EDA-AE22-418C-A65C-4E8CDB1FD33DQ41921693-E4D34A20-23E8-43E0-BC13-E320F1F19B65Q53167550-2293F0A5-17D3-4BEB-B48C-736CADBC6B47Q55352649-5FBBBAC4-AD09-4B42-8159-5D315E834B71Q55465071-249F1E42-A3C8-4FB9-B91E-6E9AC304E1ECQ58562766-DD3E24AB-3418-4757-9E06-FDA91854CFCD
P2860
Measuring tumour vascular response to antivascular and antiangiogenic drugs.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Measuring tumour vascular response to antivascular and antiangiogenic drugs.
@ast
Measuring tumour vascular response to antivascular and antiangiogenic drugs.
@en
type
label
Measuring tumour vascular response to antivascular and antiangiogenic drugs.
@ast
Measuring tumour vascular response to antivascular and antiangiogenic drugs.
@en
prefLabel
Measuring tumour vascular response to antivascular and antiangiogenic drugs.
@ast
Measuring tumour vascular response to antivascular and antiangiogenic drugs.
@en
P2860
P356
P1476
Measuring tumour vascular response to antivascular and antiangiogenic drugs.
@en
P2093
P2860
P304
P356
10.1259/BJR/30165281
P407
P478
76 Spec No 1
P577
2003-01-01T00:00:00Z